# Caterpillar Inc: financial statements, quarterly

CAT · NYSE · CIK 18230 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cat.md) · [Financials](/companies/cat/financials.md) · [Filings](/companies/cat/filings.md) · [Insiders](/companies/cat/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cat/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [16.8](/filings/0000018230-24-000053.md) | [17.1 d](/filings/0000018230-26-000008.md) | [15.8](/filings/0000018230-25-000016.md) | [16.7](/filings/0000018230-25-000040.md) | [16.1](/filings/0000018230-25-000048.md) | [16.2 d](/filings/0000018230-26-000008.md) | [14.2](/filings/0000018230-26-000021.md) | [16.6](/filings/0000018230-26-000046.md) | [17.6](/filings/0000018230-25-000048.md) | [19.1 d](/filings/0000018230-26-000008.md) | [17.4](/filings/0000018230-26-000021.md) | [20.5](/filings/0000018230-26-000046.md) |
| Cost of revenue | $bn | [10.6](/filings/0000018230-24-000053.md) | [11.0 d](/filings/0000018230-26-000008.md) | [9.7](/filings/0000018230-25-000016.md) | [10.2](/filings/0000018230-25-000040.md) | [10.1](/filings/0000018230-25-000048.md) | [10.3 d](/filings/0000018230-26-000008.md) | [9.0](/filings/0000018230-26-000021.md) | [10.8](/filings/0000018230-26-000046.md) | [11.7](/filings/0000018230-25-000048.md) | [13.3 d](/filings/0000018230-26-000008.md) | [11.3](/filings/0000018230-26-000021.md) | [12.8](/filings/0000018230-26-000046.md) |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $bn | [0.6](/filings/0000018230-24-000053.md) | [0.6 d](/filings/0000018230-26-000008.md) | [0.5](/filings/0000018230-25-000016.md) | [0.5](/filings/0000018230-25-000040.md) | [0.5](/filings/0000018230-25-000048.md) | [0.5 d](/filings/0000018230-26-000008.md) | [0.5](/filings/0000018230-26-000021.md) | [0.6](/filings/0000018230-26-000046.md) | [0.6](/filings/0000018230-25-000048.md) | [0.6 d](/filings/0000018230-26-000008.md) | [0.5](/filings/0000018230-26-000021.md) | [0.6](/filings/0000018230-26-000046.md) |
| Selling, general and administrative | $bn | [1.6](/filings/0000018230-24-000053.md) | [1.8 d](/filings/0000018230-26-000008.md) | [1.6](/filings/0000018230-25-000016.md) | [1.7](/filings/0000018230-25-000040.md) | [1.7](/filings/0000018230-25-000048.md) | [1.8 d](/filings/0000018230-26-000008.md) | [1.6](/filings/0000018230-26-000021.md) | [1.7](/filings/0000018230-26-000046.md) | [1.8](/filings/0000018230-25-000048.md) | [1.9 d](/filings/0000018230-26-000008.md) | [1.8](/filings/0000018230-26-000021.md) | [2.0](/filings/0000018230-26-000046.md) |
| Operating income | $bn | [3.4](/filings/0000018230-24-000053.md) | [3.1 d](/filings/0000018230-26-000008.md) | [3.5](/filings/0000018230-25-000016.md) | [3.5](/filings/0000018230-25-000040.md) | [3.1](/filings/0000018230-25-000048.md) | [2.9 d](/filings/0000018230-26-000008.md) | [2.6](/filings/0000018230-26-000021.md) | [2.9](/filings/0000018230-26-000046.md) | [3.1](/filings/0000018230-25-000048.md) | [2.7 d](/filings/0000018230-26-000008.md) | [3.1](/filings/0000018230-26-000021.md) | [4.3](/filings/0000018230-26-000046.md) |
| Income tax | $bn | [0.7](/filings/0000018230-24-000053.md) | [0.6 d](/filings/0000018230-26-000008.md) | [0.7](/filings/0000018230-25-000016.md) | [0.8](/filings/0000018230-25-000040.md) | [0.6](/filings/0000018230-25-000048.md) | [0.5 d](/filings/0000018230-26-000008.md) | [0.6](/filings/0000018230-26-000021.md) | [0.6](/filings/0000018230-26-000046.md) | [0.8](/filings/0000018230-25-000048.md) | [0.7 d](/filings/0000018230-26-000008.md) | [0.7](/filings/0000018230-26-000021.md) | [1.1](/filings/0000018230-26-000046.md) |
| Net income | $bn | [2.8](/filings/0000018230-24-000053.md) | [2.7 d](/filings/0000018230-26-000008.md) | [2.9](/filings/0000018230-25-000016.md) | [2.7](/filings/0000018230-25-000040.md) | [2.5](/filings/0000018230-25-000048.md) | [2.8 d](/filings/0000018230-26-000008.md) | [2.0](/filings/0000018230-26-000021.md) | [2.2](/filings/0000018230-26-000046.md) | [2.3](/filings/0000018230-25-000048.md) | [2.4 d](/filings/0000018230-26-000008.md) | [2.5](/filings/0000018230-26-000021.md) | [3.6](/filings/0000018230-26-000046.md) |
| Diluted EPS | $ per share | [5.45](/filings/0000018230-24-000053.md) | not reported | [5.75](/filings/0000018230-25-000016.md) | [5.48](/filings/0000018230-25-000040.md) | [5.06](/filings/0000018230-25-000048.md) | not reported | [4.20](/filings/0000018230-26-000021.md) | [4.62](/filings/0000018230-26-000046.md) | [4.88](/filings/0000018230-25-000048.md) | not reported | [5.47](/filings/0000018230-26-000021.md) | [7.77](/filings/0000018230-26-000046.md) |
| Basic EPS | $ per share | [5.48](/filings/0000018230-24-000053.md) | not reported | [5.78](/filings/0000018230-25-000016.md) | [5.50](/filings/0000018230-25-000040.md) | [5.09](/filings/0000018230-25-000048.md) | not reported | [4.22](/filings/0000018230-26-000021.md) | [4.64](/filings/0000018230-26-000046.md) | [4.91](/filings/0000018230-25-000048.md) | not reported | [5.50](/filings/0000018230-26-000021.md) | [7.80](/filings/0000018230-26-000046.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [6.5](/filings/0000018230-23-000056.md) | [7.0](/filings/0000018230-25-000008.md) | [5.0](/filings/0000018230-24-000020.md) | [4.3](/filings/0000018230-24-000045.md) | [5.6](/filings/0000018230-24-000053.md) | [6.9](/filings/0000018230-26-000008.md) | [3.6](/filings/0000018230-25-000016.md) | [5.4](/filings/0000018230-25-000040.md) | [7.5](/filings/0000018230-25-000048.md) | [10.0](/filings/0000018230-26-000046.md) | [4.1](/filings/0000018230-26-000021.md) | [6.7](/filings/0000018230-26-000046.md) |
| Current assets | $bn | [48.0](/filings/0000018230-23-000056.md) | [46.9](/filings/0000018230-25-000008.md) | [43.7](/filings/0000018230-24-000020.md) | [43.1](/filings/0000018230-24-000045.md) | [44.9](/filings/0000018230-24-000053.md) | [45.7](/filings/0000018230-26-000008.md) | [43.0](/filings/0000018230-25-000016.md) | [46.8](/filings/0000018230-25-000040.md) | [49.8](/filings/0000018230-25-000048.md) | [52.5](/filings/0000018230-26-000046.md) | [48.6](/filings/0000018230-26-000021.md) | [54.5](/filings/0000018230-26-000046.md) |
| Total assets | $bn | [86.8](/filings/0000018230-23-000056.md) | [87.5](/filings/0000018230-25-000008.md) | [83.7](/filings/0000018230-24-000020.md) | [83.3](/filings/0000018230-24-000045.md) | [86.3](/filings/0000018230-24-000053.md) | [87.8](/filings/0000018230-26-000008.md) | [85.0](/filings/0000018230-25-000016.md) | [90.3](/filings/0000018230-25-000040.md) | [93.7](/filings/0000018230-25-000048.md) | [98.6](/filings/0000018230-26-000046.md) | [95.6](/filings/0000018230-26-000021.md) | [103](/filings/0000018230-26-000046.md) |
| Current liabilities | $bn | [33.1](/filings/0000018230-23-000056.md) | [34.7](/filings/0000018230-25-000008.md) | [32.4](/filings/0000018230-24-000020.md) | [33.6](/filings/0000018230-24-000045.md) | [32.2](/filings/0000018230-24-000053.md) | [32.3](/filings/0000018230-26-000008.md) | [32.6](/filings/0000018230-25-000016.md) | [34.9](/filings/0000018230-25-000040.md) | [36.0](/filings/0000018230-25-000048.md) | [36.6](/filings/0000018230-26-000046.md) | [35.9](/filings/0000018230-26-000021.md) | [39.8](/filings/0000018230-26-000046.md) |
| Total liabilities | $bn | [66.3](/filings/0000018230-23-000056.md) | [68.0](/filings/0000018230-25-000008.md) | [66.1](/filings/0000018230-24-000020.md) | [66.2](/filings/0000018230-24-000045.md) | [66.9](/filings/0000018230-24-000053.md) | [68.3](/filings/0000018230-26-000008.md) | [66.9](/filings/0000018230-25-000016.md) | [71.7](/filings/0000018230-25-000040.md) | [73.1](/filings/0000018230-25-000048.md) | [77.3](/filings/0000018230-26-000046.md) | [76.9](/filings/0000018230-26-000021.md) | [83.2](/filings/0000018230-26-000046.md) |
| Long-term debt | $bn | not reported | [24.5](/filings/0000018230-25-000008.md) | not reported | not reported | not reported | [27.4](/filings/0000018230-26-000008.md) | not reported | not reported | not reported | [30.7](/filings/0000018230-26-000008.md) | not reported | not reported |
| Short-term borrowings | $bn | not reported | [4.6](/filings/0000018230-25-000008.md) | not reported | not reported | not reported | [4.4](/filings/0000018230-26-000008.md) | not reported | not reported | not reported | [5.5](/filings/0000018230-26-000008.md) | not reported | not reported |
| Shareholders' equity | $bn | [20.5](/filings/0000018230-24-000053.md) | [19.5](/filings/0000018230-26-000008.md) | [17.6](/filings/0000018230-25-000040.md) | [17.1](/filings/0000018230-25-000048.md) | [19.4](/filings/0000018230-25-000048.md) | [19.5](/filings/0000018230-26-000046.md) | [18.1](/filings/0000018230-26-000046.md) | [18.7](/filings/0000018230-26-000046.md) | [20.7](/filings/0000018230-25-000048.md) | [21.3](/filings/0000018230-26-000046.md) | [18.7](/filings/0000018230-26-000046.md) | [19.4](/filings/0000018230-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4,060 d](/filings/0000018230-24-000053.md) | [4,003 d](/filings/0000018230-26-000008.md) | [2,052](/filings/0000018230-25-000016.md) | [3,021 d](/filings/0000018230-25-000040.md) | [3,569 d](/filings/0000018230-25-000048.md) | [3,393 d](/filings/0000018230-26-000008.md) | [1,289](/filings/0000018230-26-000021.md) | [3,122 d](/filings/0000018230-26-000046.md) | [3,737 d](/filings/0000018230-25-000048.md) | [3,591 d](/filings/0000018230-26-000008.md) | [1,870](/filings/0000018230-26-000021.md) | [4,371 d](/filings/0000018230-26-000046.md) |
| Capital expenditure | $m | [378 d](/filings/0000018230-24-000053.md) | [536 d](/filings/0000018230-26-000008.md) | [500](/filings/0000018230-25-000016.md) | [341 d](/filings/0000018230-25-000040.md) | [444 d](/filings/0000018230-25-000048.md) | [703 d](/filings/0000018230-26-000008.md) | [710](/filings/0000018230-26-000021.md) | [555 d](/filings/0000018230-26-000046.md) | [658 d](/filings/0000018230-25-000048.md) | [898 d](/filings/0000018230-26-000008.md) | [728](/filings/0000018230-26-000021.md) | [587 d](/filings/0000018230-26-000046.md) |
| Dividends paid | $m | [663 d](/filings/0000018230-24-000053.md) | [662 d](/filings/0000018230-26-000008.md) | [648](/filings/0000018230-25-000016.md) | [635 d](/filings/0000018230-25-000040.md) | [683 d](/filings/0000018230-25-000048.md) | [680 d](/filings/0000018230-26-000008.md) | [674](/filings/0000018230-26-000021.md) | [662 d](/filings/0000018230-26-000046.md) | [707 d](/filings/0000018230-25-000048.md) | [706 d](/filings/0000018230-26-000008.md) | [703](/filings/0000018230-26-000021.md) | [696 d](/filings/0000018230-26-000046.md) |
| Share repurchases | $m | [380 d](/filings/0000018230-24-000053.md) | [2,766 d](/filings/0000018230-26-000008.md) | [4,455](/filings/0000018230-25-000016.md) | [1,820 d](/filings/0000018230-25-000040.md) | [782 d](/filings/0000018230-25-000048.md) | [640 d](/filings/0000018230-26-000008.md) | [3,660](/filings/0000018230-26-000021.md) | [828 d](/filings/0000018230-26-000046.md) | [362 d](/filings/0000018230-25-000048.md) | [340 d](/filings/0000018230-26-000008.md) | [5,028](/filings/0000018230-26-000021.md) | [1,494 d](/filings/0000018230-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [528](/filings/0000018230-23-000056.md) | [519](/filings/0000018230-24-000020.md) | [515](/filings/0000018230-24-000045.md) | [513](/filings/0000018230-24-000053.md) | [497](/filings/0000018230-25-000016.md) | [490](/filings/0000018230-25-000040.md) | [487](/filings/0000018230-25-000048.md) | [477](/filings/0000018230-26-000021.md) | [472](/filings/0000018230-26-000046.md) | [471](/filings/0000018230-25-000048.md) | [466](/filings/0000018230-26-000021.md) | [463](/filings/0000018230-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 459,674,889 at 2026-06-30, from the cover of the [10-Q filed 2026-08-05](/filings/0000018230-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.